Literature DB >> 9098015

Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.

H Yamamoto1, F Itoh, Y Adachi, H Sakamoto, M Adachi, Y Hinoda, K Imai.   

Abstract

BACKGROUND & AIMS: Matrix metalloproteinases have been implicated in invasion and metastasis of various human malignant tumors, but its role in human hepatocellular carcinoma has not been characterized in detail. The aim of the present study was to examine the secretion and activation of metalloproteinases in liver tissues from patients with hepatocellular carcinoma and evaluate its relationship with clinicopathologic characteristics.
METHODS: Activity of metalloproteinases was measured in 30 surgical specimen pairs of human primary hepatocellular carcinoma and adjacent nontumoral liver and in five cultured human hepatoma cell lines using zymography. A comparison of this activity with clinicopathological features was made.
RESULTS: In the liver tissues, enhanced secretion of active forms of gelatinase A and matrilysin was associated with portal venous invasion (P < 0.05, respectively), intrahepatic metastasis (P < 0.05, respectively), and recurrence within the first postoperative year (P < 0.01 and P < 0.05, respectively). Enhanced messenger RNA expression for membrane type 1-matrix metalloproteinase was observed in 22 of 30 cases and associated with capsule invasion and the activation of progelatinase A (P < 0.05, respectively).
CONCLUSIONS: Active gelatinase A, active matrilysin, and membrane type 1-matrix metalloproteinase may play an important role in tumor spread of human hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098015     DOI: 10.1016/s0016-5085(97)70143-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Authors:  K Murakami; R Sakukawa; T Ikeda; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology.

Authors:  Gerald U Denk; Shi-Ying Cai; Wen-Sheng Chen; Aiping Lin; Carol J Soroka; James L Boyer
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

5.  Caffeoyl pyrrolidine derivative LY52 inhibits hepatocellular carcinoma invasion via suppressing matrix metalloproteinase-2.

Authors:  Xin Zhao; Huanli Xu; Yoshinori Inagaki; Norihiro Kokudo; Wenfang Xu; Jiahong Dong; Wei Tang
Journal:  Hepatol Int       Date:  2010-12-21       Impact factor: 6.047

6.  MMP-7 as a prognostic marker in colorectal cancer.

Authors:  Selja Koskensalo; Johanna Louhimo; Stig Nordling; Jaana Hagström; Caj Haglund
Journal:  Tumour Biol       Date:  2010-08-28

7.  High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Wanhua Ren; Shifeng Xu; Zhen Yang; Aiju Fang; Chengyong Qin
Journal:  Med Oncol       Date:  2012-01-15       Impact factor: 3.064

8.  Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma.

Authors:  Eman R Youness; Mohamed El Nemr; F S Oraby; Nadia M Ahmed; Mohamed A Moghni; Hanan F Aly; Hanaa H Ahmed
Journal:  Indian J Clin Biochem       Date:  2013-09-08

9.  Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma.

Authors:  Thomas Longerich; Kai Breuhahn; Margarete Odenthal; Katharina Petmecky; Peter Schirmacher
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

10.  Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.

Authors:  Toshikuni Oka; Hiroyuki Yamamoto; Shigeru Sasaki; Masanori Ii; Keiichi Hizaki; Hiroaki Taniguchi; Yasushi Adachi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.